Listed

Xtant Medical Holdings, Inc.

XTNTNYSECIK 1453593HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$23.0mRevenue, Q2 FY2026, three months to 2026-06-30$23.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 11, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$23.0mRevenue, Q2 FY2026, three months to 2026-06-30$23.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure−35.0% on a year earlier
  • Gross margin57.9%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $13.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Revenue: $23.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure−10.7 pts on a year earlier
  • Operating margin−39.8%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$9.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Revenue: $23.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure−52.9 pts on a year earlier
  • Net margin−40.9%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$9.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Revenue: $23.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure−50.9 pts on a year earlier
  • Diluted EPS−$0.07Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figureSign changed from a year earlier
  • Free cash flow−$7.6mFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$7.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001493152-26-036981. Derived: 6-month figure less the 3-month figure.Capital expenditure: $247.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001493152-26-036981. Derived: 6-month figure less the 3-month figure.Report this figureSign changed from a year earlier

Last eight quarters

Full statements
Revenue$23.0mGross margin 57.9%
Diluted EPS−$0.07, Q2 FY2026
Free cash flow−$7.6m, Q2 FY2026
Xtant Medical Holdings, Inc., key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$m27.9Revenue, Q3 FY2024, three months to 2024-09-30$27.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure31.5Revenue, Q4 FY2024, three months to 2024-12-31$31.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure32.9Revenue, Q1 FY2025, three months to 2025-03-31$32.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure35.4Revenue, Q2 FY2025, three months to 2025-06-30$35.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure33.3Revenue, Q3 FY2025, three months to 2025-09-30$33.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure32.4Revenue, Q4 FY2025, three months to 2025-12-31$32.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure20.9Revenue, Q1 FY2026, three months to 2026-03-31$20.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure23.0Revenue, Q2 FY2026, three months to 2026-06-30$23.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure
Gross margin%58.4%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $16.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Revenue: $27.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure50.8%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $16.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Revenue: $31.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure61.5%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $20.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Revenue: $32.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure68.6%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $24.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Revenue: $35.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure66.1%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $22.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Revenue: $33.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure54.9%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $17.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Revenue: $32.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure57.3%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $12.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Revenue: $20.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure57.9%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $13.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Revenue: $23.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure
Operating margin%(13.5%)Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: −$3.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Revenue: $27.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure(6.0%)Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: −$1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Revenue: $31.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure3.2%Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Revenue: $32.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure13.1%Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $4.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Revenue: $35.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure7.6%Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: $2.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Revenue: $33.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure(2.9%)Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: −$944.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Revenue: $32.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure(14.0%)Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$2.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Revenue: $20.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure(39.8%)Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$9.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Revenue: $23.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure
Net margin%(18.0%)Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: −$5.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Revenue: $27.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure(10.0%)Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: −$3.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Revenue: $31.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure0.2%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $58.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Revenue: $32.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure10.0%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $3.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Revenue: $35.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure3.9%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $1.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Revenue: $33.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure0.2%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $57.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Revenue: $32.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure(14.8%)Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: −$3.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Revenue: $20.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure(40.9%)Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$9.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Revenue: $23.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure
Diluted EPS$ per share(0.04)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figurenot reported (Diluted EPS not reported)0.00Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure0.02Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure0.01Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figurenot reported (Diluted EPS not reported)(0.02)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure(0.07)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure
Free cash flow$m(3.8)Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: −$1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001493152-25-021512. Derived: 9-month figure less the 6-month figure.Capital expenditure: $2.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001493152-25-021512. Derived: 9-month figure less the 6-month figure.Report this figure(0.0)Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $665.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Capital expenditure: $672.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure0.1Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Capital expenditure: $1.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure0.9Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001493152-26-036981. Derived: 6-month figure less the 3-month figure.Capital expenditure: $366.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001493152-26-036981. Derived: 6-month figure less the 3-month figure.Report this figure4.2Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $4.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001493152-25-021512. Derived: 9-month figure less the 6-month figure.Capital expenditure: $430.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001493152-25-021512. Derived: 9-month figure less the 6-month figure.Report this figure5.0Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $5.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Capital expenditure: $395.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure(2.3)Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: −$2.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Capital expenditure: $194.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure(7.6)Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$7.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001493152-26-036981. Derived: 6-month figure less the 3-month figure.Capital expenditure: $247.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001493152-26-036981. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$133.9mGross margin 62.9%
Diluted EPS$0.03, FY2025
Free cash flow$10.2m, FY2025
Xtant Medical Holdings, Inc., key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m55.3Revenue, FY2021, twelve months to 2021-12-31$55.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-07, accession 0001493152-23-006881.Report this figure58.0Revenue, FY2022, twelve months to 2022-12-31$58.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-04-01, accession 0001493152-24-012145.Report this figure91.3Revenue, FY2023, twelve months to 2023-12-31$91.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-06, accession 0001493152-25-009391.Report this figure117Revenue, FY2024, twelve months to 2024-12-31$117.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001493152-26-013792.Report this figure134Revenue, FY2025, twelve months to 2025-12-31$133.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001493152-26-013792.Report this figure
Gross margin%58.8%Gross margin, FY2021, twelve months to 2021-12-31. gross profit / revenueGross profit: $32.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2023-03-07, accession 0001493152-23-006881.Revenue: $55.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-07, accession 0001493152-23-006881.Report this figure55.4%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $32.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-04-01, accession 0001493152-24-012145.Revenue: $58.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-04-01, accession 0001493152-24-012145.Report this figure60.8%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $55.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-06, accession 0001493152-25-009391.Revenue: $91.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-06, accession 0001493152-25-009391.Report this figure58.2%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $68.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-31, accession 0001493152-26-013792.Revenue: $117.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001493152-26-013792.Report this figure62.9%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $84.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-31, accession 0001493152-26-013792.Revenue: $133.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001493152-26-013792.Report this figure
Operating margin%(7.0%)Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: −$3.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2023-03-07, accession 0001493152-23-006881.Revenue: $55.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-07, accession 0001493152-23-006881.Report this figure(11.7%)Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: −$6.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-04-01, accession 0001493152-24-012145.Revenue: $58.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-04-01, accession 0001493152-24-012145.Report this figure(11.1%)Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: −$10.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-06, accession 0001493152-25-009391.Revenue: $91.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-06, accession 0001493152-25-009391.Report this figure(10.3%)Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: −$12.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-013792.Revenue: $117.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001493152-26-013792.Report this figure5.4%Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: $7.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-013792.Revenue: $133.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001493152-26-013792.Report this figure
Net margin%(8.8%)Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: −$4.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2023-03-07, accession 0001493152-23-006881.Revenue: $55.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-07, accession 0001493152-23-006881.Report this figure(14.6%)Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: −$8.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-04-01, accession 0001493152-24-012145.Revenue: $58.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-04-01, accession 0001493152-24-012145.Report this figure0.7%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $660.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-06, accession 0001493152-25-009391.Revenue: $91.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-06, accession 0001493152-25-009391.Report this figure(14.0%)Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: −$16.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-013792.Revenue: $117.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001493152-26-013792.Report this figure3.7%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $5.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-013792.Revenue: $133.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001493152-26-013792.Report this figure
Diluted EPS$ per share(0.06)Diluted EPS, FY2021, twelve months to 2021-12-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2023-03-07, accession 0001493152-23-006881.Report this figure(0.09)Diluted EPS, FY2022, twelve months to 2022-12-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-04-01, accession 0001493152-24-012145.Report this figure0.01Diluted EPS, FY2023, twelve months to 2023-12-31$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-06, accession 0001493152-25-009391.Report this figure(0.12)Diluted EPS, FY2024, twelve months to 2024-12-31−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-31, accession 0001493152-26-013792.Report this figure0.03Diluted EPS, FY2025, twelve months to 2025-12-31$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-31, accession 0001493152-26-013792.Report this figure
Free cash flow$m(1.7)Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $439.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2023-03-07, accession 0001493152-23-006881.Capital expenditure: $2.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2023-03-07, accession 0001493152-23-006881.Report this figure(7.1)Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: −$5.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-04-01, accession 0001493152-24-012145.Capital expenditure: $1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-04-01, accession 0001493152-24-012145.Report this figure(11.0)Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: −$9.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-06, accession 0001493152-25-009391.Capital expenditure: $1.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-06, accession 0001493152-25-009391.Report this figure(16.0)Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$11.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001493152-26-013792.Capital expenditure: $4.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001493152-26-013792.Report this figure10.2Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $12.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001493152-26-013792.Capital expenditure: $2.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001493152-26-013792.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Xtant Medical Holdings, Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
Nantahala Capital Management, LLC2026-06-30$28.8m68,394,000Unchanged
Nantahala Capital Management, LLC2026-06-30$28.8m68,394,000Unchanged
AWM Investment Company, Inc.2026-06-30$2.5m5,976,910Unchanged
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$848.1k2,014,603Unchanged
RENAISSANCE TECHNOLOGIES LLC2026-06-30$393.7k935,119Reduced−52,291
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$217.8k517,133Reduced−12,081
Crescent Grove Advisors, LLC2026-06-30$173.5k412,024Unchanged
NANO CAP NEW MILLENNIUM GROWTH FUND L P2026-06-30$168.4k400,000Added+50,000
VANGUARD FIDUCIARY TRUST CO2026-06-30$108.6k257,988Unchanged
CITADEL ADVISORS LLC2026-06-30$80.6k191,369Added+30,358

Recent filings

All 1,105 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Xtant Medical Holdings, Inc., recent filings
FiledFormWhat it isAccession number
2026-08-1107:15 ET10-QQuarterly reportPeriod 2026-06-300001493152-26-036981
2026-08-1107:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-26-036979
2026-08-0716:15 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001493152-26-036586
2026-06-2307:00 ETDEF 14AProxy statementPeriod 2026-06-230001493152-26-029699
2026-05-1307:15 ET10-QQuarterly reportPeriod 2026-03-310001493152-26-022604
2026-05-1307:05 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-26-022600
2026-04-1309:20 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-26-016308
2026-03-3107:16 ET10-KAnnual reportPeriod 2025-12-310001493152-26-013792
2026-03-3107:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-26-013788
2026-03-0208:15 ET8-K8.01 Other events0001493152-26-008453

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Mar 31, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1453593
Tickers
XTNT
Exchange
NYSE
SIC code
3841 Surgical & Medical Instruments & Apparatus
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Non-accelerated filer<br>Smaller reporting company
Former names
Bacterin International Holdings, Inc. (to 2015-08-03); K KITZ INC (to 2010-05-21)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:40 ET. Listed shows no prices and gives no investment advice.